Global CRISPR Technology Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
"Global CRISPR Technology Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global CRISPR technology market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global CRISPR technology market report have been segmented on the product, application, and region.
CRISPR is an abbreviation of the clustered regularly interspaced short palindromic repeats, which is a simple and efficient tool for genome editing. CRISPR technology can easily alter DNA sequences and can modify gene function thereby finds many potential applications which includes correcting genetic defects, improving crops, and treating and preventing the spread of diseases, etc.
Increasing focus on development of gene therapeutics, owing to growing prevalence of various genetic disorders such as haemophilia, thalassemia, and sickle cell anaemia is major factor expected to drive growth of target market over the forecast period. In addition, increasing public and private finding for development of novel therapies is in turn expected to boost growth of target market over the forecast period. Growing adoption for CRISPR technology in various applications, coupled with increasing demand of CRISPR technology in R&D for advanced therapies for cancer and infectious diseases is some among the other factor expected to support growth of the target market.
However, high costs associated with using CRISPR is major factor expected to limit growth of the global market, to certain extent. In addition, lack of standardized regulations is expected to hamper growth of the target market over the forecast period.
Based on application, the global CRISPR technology market is segmented based on biological research, agricultural biotech, industrial biotech, and therapeutics and drug discovery. The therapeutics and drug discovery segment is expected to register fastest growth over the forecast period.
Market in North America accounted for significant revenue share of the global CRISPR technology market in terms of revenue contribution as compared to that of markets in other regions, in 2017. High adoption of advance technologies coupled with presence of major players in marker are factors expected to boost growth of North America CRISPR technology market. Europe accounts for second-highest revenue share contribution to the global market, registering a revenue share of XX.X%, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively.
In addition, the market in the Asia Pacific is projected to register highest growth in terms of revenue over the next 10 years. Increasing prevalence of various genetic diseases coupled with increasing government investments in R&D are another majors factor expected to boost growth of the market in the region over the forecast period.
The Middle East & Africa market is expected to register a CAGR of XX.X% during the forecast period. The market in Latin America is expected to register considerate growth in the global CRISPR technology market over the forecast period.
Global CRISPR Technology Market Segmentation:
Segmentation on the basis of product:
- Plasmids and Vectors
- Others (Control Kits and gRNA)
Segmentation on the basis of application:
- Biological Research
- Agricultural Biotech
- Industrial Biotech
- Therapeutics and Drug Discovery
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- GenScript Corporation
- Integrated DNA Technologies, Inc.
- Horizon Discovery Group
- Agilent Technologies, Inc.
- Cellecta, Inc.
- GeneCopoeia, Inc.
- New England Biolabs, Inc.
- Origene Technologies, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!